相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Breast Cancer Statistics, 2015: Convergence of Incidence Rates Between Black and White Women
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Is PET/CT Necessary in the Management of Early Breast Cancer?
Gul Nihal Nursal et al.
CLINICAL NUCLEAR MEDICINE (2016)
18F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer
Gary A. Ulaner et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy
Nurhan Ergul et al.
ACTA RADIOLOGICA (2015)
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
E. Senkus et al.
ANNALS OF ONCOLOGY (2015)
Utility of 18F FDG-PET/CT for predicting prognosis of luminal-type breast cancer
Kenjiro Aogi et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Risk stratification in patients with advanced-stage breast cancer by pretreatment [18F]FDG PET/CT
Suyun Chen et al.
CANCER (2015)
SEOM clinical guidelines in early-stage breast cancer 2015
J. A. Garcia-Saenz et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2015)
SEOM clinical guidelines in metastatic breast cancer 2015
J. Gavila et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2015)
Basal 18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography as a prognostic biomarker in patients with locally advanced breast cancer
Ana Maria Garcia Vicente et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Association between 18F-FDG uptake and molecular subtype of breast cancer
Kazuhiro Kitajima et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
18 F-FDG PET/CT for initial staging in breast cancer patients - Is there a relevant impact on treatment planning compared to conventional staging modalities?
J. Krammer et al.
EUROPEAN RADIOLOGY (2015)
Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma
Molly P. Hogan et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Prognostic impact of 18F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer
D. Groheux et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer
Bas B. Koolen et al.
ACTA ONCOLOGICA (2014)
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
F. Cardoso et al.
ANNALS OF ONCOLOGY (2014)
Additional value of F-18 FDG PET/CT for initial staging in breast cancer with clinically negative axillary nodes
Young Jin Jeong et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
18F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations
Alexandre Cochet et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Detection of internal mammary lymph node metastasis with 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with stage III breast cancer
Min Jung Seo et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from 68Ga-RGD PET/CT and 18F-FDG PET/CT
Hai-Jeon Yoon et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Staging the axilla in breast cancer patients with 18F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?
Dimitri Bellevre et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes
Hye Ryoung Koo et al.
EUROPEAN RADIOLOGY (2014)
Retrospective Analysis of 18F-FDG PET/CT for Staging Asymptomatic Breast Cancer Patients Younger Than 40 Years
Christopher C. Riedl et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study
Takayuki Kadoya et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
18F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer
Laurence Champion et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Molecular subtypes of breast cancer: metabolic correlation with 18F-FDG PET/CT
Ana Maria Garcia Vicente et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Breast cancer survival in the US and Europe: a CONCORD high-resolution study
Claudia Allemani et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The Comparative Study of Ultrasonography, Contrast-Enhanced MRI, and 18F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast Cancer
Seung Ook Hwang et al.
JOURNAL OF BREAST CANCER (2013)
18F-FDG PET/CT in Staging Patients with Locally Advanced or Inflammatory Breast Cancer: Comparison to Conventional Staging
David Groheux et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Correlation of 18F-fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma
Ozgul Ekmekcioglu et al.
NUCLEAR MEDICINE COMMUNICATIONS (2013)
Role of 18F-FDG PET/CT in identifying distant metastatic disease missed by conventional imaging in patients with locally advanced breast cancer
Kuruva Manohar et al.
NUCLEAR MEDICINE COMMUNICATIONS (2013)
The impact of PET/CT imaging performed in the early postoperative period on the management of breast cancer patients
Feyza Sen et al.
NUCLEAR MEDICINE COMMUNICATIONS (2013)
Comparison of 18FDG PET-CT and bone scintigraphy for detection of bone metastases in breast cancer patients. A meta-analysis
Jian Rong et al.
SURGICAL ONCOLOGY-OXFORD (2013)
18FDG PET-CT for diagnosis of distant metastases in breast cancer patients. A meta-analysis
Shikai Hong et al.
SURGICAL ONCOLOGY-OXFORD (2013)
The Prognostic Value of 18F-FDGPET/CT for Early Recurrence in Operable Breast Cancer: Comparison with TNM Stage
Joo O. Hyun et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients
Carolin Riegger et al.
ACTA RADIOLOGICA (2012)
Increased FDG uptake in breast cancer is associated with prognostic factors
Yasemin Sanli et al.
ANNALS OF NUCLEAR MEDICINE (2012)
Preoperative PET/CT in early-stage breast cancer
M. Bernsdorf et al.
ANNALS OF ONCOLOGY (2012)
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques
Bas B. Koolen et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy
Bas B. Koolen et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy
B. B. Koolen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients
C. Riegger et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
The Effects of Preoperative 18F-FDG PET/CT in Breast Cancer Patients in Comparison to the Conventional Imaging Study
Young Jin Choi et al.
JOURNAL OF BREAST CANCER (2012)
18F-FDG Uptake by Metastatic Axillary Lymph Nodes on Pretreatment PET/CT as a Prognostic Factor for Recurrence in Patients with Invasive Ductal Breast Cancer
Bong-Il Song et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer
David Groheux et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Cost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer
Y. Meng et al.
EJSO (2011)
Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: A systematic review and meta-analysis
K. L. Cooper et al.
EJSO (2011)
Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer
David Groheux et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
The Yield of 18F-FDG PET/CT in Patients with Clinical Stage IIA, IIB, or IIIA Breast Cancer: A Prospective Study
David Groheux et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
FDG-PET/CT Compared with Conventional Imaging in the Detection of Distant Metastases of Primary Breast Cancer
Naoki Niikura et al.
ONCOLOGIST (2011)
Additional Value of PET-CT in Staging of Clinical Stage IIB and III Breast Cancer
Isabelle Segaert et al.
BREAST JOURNAL (2010)
18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) Imaging in the Staging and Prognosis of Inflammatory Breast Cancer
Jean-Louis Alberini et al.
CANCER (2009)
Retrospective Studyof 18F-FDG PET/CT in the Diagnosis of Inflammatory Breast Cancer: Preliminary Data
Selin Carkaci et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Clinicopathological and prognostic relevance of uptake level using F-18-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (F-18-FDG PET/CT) in primary breast cancer
Shigeto Ueda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2008)
Preoperative staging of large primary breast cancer with [18F] fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures
David Fuster et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cost-effectiveness of positron emission tomography in breast cancer
JS Sloka et al.
MOLECULAR IMAGING AND BIOLOGY (2005)
分享论文
